is retatrutide stronger than semaglutide vs. Semaglutide: Weight Loss Comparison Retatrutide vs. Tirzepatide vs. Semaglutide

GLP-1 Receptor Agonist Market Size The global GLP-1 receptor agonist market size was valued at USD 24.4 billion in 2023 and is expected to grow at 9.7% CAGR from 2024 to 2032, driven by rising incidences of type 2 diabetes and obesity globally

This is primarily due to the downregulation of enzymes such as branched-chain -keto acid dehydrogenase

This has led some researchers to target 9mg rather than 12mg as their maintenance dose, especially given that the difference (2.3 percentage points) may not justify the additional side effect burden for all individuals

At the same time, successful weight loss has never been about simply choosing the newest medication